Printer Friendly

New Market Research Report: Presidio Pharmaceuticals, Inc. - Product Pipeline Review - 2013.

[USPRwire, Fri Aug 16 2013] Global Markets Direct's pharmaceuticals report, "Presidio Pharmaceuticals, Inc. - Product Pipeline Review - 2013" provides data on the Presidio Pharmaceuticals, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Presidio Pharmaceuticals, Inc.'s corporate website, SEC filings, investor presentations and featured press releases, both from Presidio Pharmaceuticals, Inc. and industry-specific third party sources, put together by Global Markets Direct's team.

Full Report Details at



* Presidio Pharmaceuticals, Inc. - Brief Presidio Pharmaceuticals, Inc. overview including business description, key information and facts, and its locations and subsidiaries.

* Review of current pipeline of Presidio Pharmaceuticals, Inc. human therapeutic division.

* Overview of pipeline therapeutics across various therapy areas.

* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.

* Product profiles for late stage and clinical stage products of Presidio Pharmaceuticals, Inc. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.

* Recent updates of the Presidio Pharmaceuticals, Inc.'s pipeline in the last quarter.

* Key discontinued and dormant projects.

* Latest news and deals relating to the products.

Reasons to Get this Report

* Evaluate Presidio Pharmaceuticals, Inc.'s strategic position with total access to detailed information on its product pipeline.

* Assess the growth potential of Presidio Pharmaceuticals, Inc. in its therapy areas of focus.

* Identify new drug targets and therapeutic classes in the Presidio Pharmaceuticals, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.

* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.

* Exploit collaboration and partnership opportunities with Presidio Pharmaceuticals, Inc..

* Avoid Intellectual Property Rights related issues.

* Explore the dormant and discontinued projects of Presidio Pharmaceuticals, Inc. and identify potential opportunities in those areas.

Companies Mentioned in this Report: Presidio Pharmaceuticals, Inc.

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

You may also be interested in these related reports:

- Presidio Pharmaceuticals, Inc. - Product Pipeline Review - 2012

- Spectrum Pharmaceuticals, Inc. - Product Pipeline Review - 2013

- Isis Pharmaceuticals, Inc. - Product Pipeline Review - 2013

- Astex Pharmaceuticals, Inc. - Product Pipeline Review - 2013

- Regeneron Pharmaceuticals, Inc. - Product Pipeline Review - 2013

Copyright 2013 USPRwire

Provided by an company
COPYRIGHT 2013 SyndiGate Media Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2013 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Article Type:Report
Date:Aug 16, 2013
Previous Article:Market Report, "Aplastic Anemia - Pipeline Review, H1 2013", published.
Next Article:Market Report, "Viventia Biotechnologies Inc. - Product Pipeline Review - 2013", published.

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters